Gentian Diagnostics AS (GENT) - Total Liabilities

Latest as of December 2025: Nkr53.58 Million NOK ≈ $5.64 Million USD

Based on the latest financial reports, Gentian Diagnostics AS (GENT) has total liabilities worth Nkr53.58 Million NOK (≈ $5.64 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Gentian Diagnostics AS to track the company's year-over-year net asset growth rate.

Gentian Diagnostics AS - Total Liabilities Trend (2013–2025)

This chart illustrates how Gentian Diagnostics AS's total liabilities have evolved over time, based on quarterly financial data.

Gentian Diagnostics AS Competitors by Total Liabilities

The table below lists competitors of Gentian Diagnostics AS ranked by their total liabilities.

Company	Country	Total Liabilities
Ci&T Inc NYSE:CINT	USA	$249.99 Million
Home Federal Bancorp Louisiana NASDAQ:HFBL	USA	$583.64 Million
ImageneBio, Inc. NASDAQ:IMA	USA	$13.36 Million
TGS Dis Ticaret AS IS:TGSAS	Turkey	TL17.82 Billion
CUE Energy Resources Ltd AU:CUE	Australia	AU$66.83 Million
First Seacoast Bancorp NASDAQ:FSEA	USA	$546.47 Million
Talaad Thai Leasehold Property Fund BK:TTLPF	Thailand	฿42.32 Million
Speciality Restaurants Limited NSE:SPECIALITY	India	Rs1.99 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Gentian Diagnostics AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GENT market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	3.10	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gentian Diagnostics AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gentian Diagnostics AS (2013–2025)

The table below shows the annual total liabilities of Gentian Diagnostics AS from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Nkr53.58 Million ≈ $5.64 Million	+50.45%
2024-12-31	Nkr35.61 Million ≈ $3.75 Million	+3.52%
2023-12-31	Nkr34.40 Million ≈ $3.62 Million	+2.33%
2022-12-31	Nkr33.62 Million ≈ $3.54 Million	-9.19%
2021-12-31	Nkr37.02 Million ≈ $3.90 Million	-9.00%
2020-12-31	Nkr40.69 Million ≈ $4.28 Million	+114.78%
2019-12-31	Nkr18.94 Million ≈ $1.99 Million	+56.47%
2018-12-31	Nkr12.11 Million ≈ $1.27 Million	+38.29%
2017-12-31	Nkr8.75 Million ≈ $921.24K	+18.00%
2016-12-31	Nkr7.42 Million ≈ $780.68K	+51.53%
2015-12-31	Nkr4.90 Million ≈ $515.21K	-58.78%
2014-12-31	Nkr11.88 Million ≈ $1.25 Million	-5.36%
2013-12-31	Nkr12.55 Million ≈ $1.32 Million	--

About Gentian Diagnostics AS

OL:GENT Norway Medical Devices

Market Cap

$59.56 Million

Nkr566.00 Million NOK

Market Cap Rank

#21328 Global

#190 in Norway

Share Price

Nkr36.70

Change (1 day)

+2.51%

52-Week Range

Nkr35.80 - Nkr64.80

All Time High

Nkr86.00